Exhalon.io

Born from a five-year collaboration between Hopital Foch's esteemed respiratory department, UVSQ’s medicine faculty, and participation in projects such as RHU RECORDS and FHU SEPSIS, Exhalon.io is the first-ever biomarker discovery platform based on real-time breath analysis. By analyzing human breath, we unveil innovative diagnostic, monitoring, and therapy prediction solutions for the development of novel personalized medications and medical devices. Our platform has demonstrated its value in studies encompassing Lung Cancer, COPD, Asthma, Cystic Fibrosis, and various other respiratory and non respiratory diseases.